Tirzepatide Therapy in a Patient with Type 2 Diabetes Mellitus, Chylomicronemia, and Heterozygosity for Lipoprotein Lipase Deficiency

BACKGROUND/OBJECTIVE: A patient with well-controlled type 2 diabetes mellitus (T2DM) and a heterozygote for lipoprotein lipase deficiency (HeLPL) presented with chronic chylomicrons (CMs). Some patients with T2DM can develop CMs due to poor glycemic control or genetic defects that result in a decrea...

Descripción completa

Detalles Bibliográficos
Autor principal: Babirak, Stephan Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association of Clinical Endocrinology 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382611/
https://www.ncbi.nlm.nih.gov/pubmed/37520761
http://dx.doi.org/10.1016/j.aace.2023.05.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382611/
https://www.ncbi.nlm.nih.gov/pubmed/37520761
http://dx.doi.org/10.1016/j.aace.2023.05.005

Ejemplares similares